Correlation Between NewAmsterdam Pharma and Aldeyra
Can any of the company-specific risk be diversified away by investing in both NewAmsterdam Pharma and Aldeyra at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NewAmsterdam Pharma and Aldeyra into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NewAmsterdam Pharma and Aldeyra, you can compare the effects of market volatilities on NewAmsterdam Pharma and Aldeyra and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NewAmsterdam Pharma with a short position of Aldeyra. Check out your portfolio center. Please also check ongoing floating volatility patterns of NewAmsterdam Pharma and Aldeyra.
Diversification Opportunities for NewAmsterdam Pharma and Aldeyra
-0.71 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between NewAmsterdam and Aldeyra is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding NewAmsterdam Pharma and Aldeyra in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aldeyra and NewAmsterdam Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NewAmsterdam Pharma are associated (or correlated) with Aldeyra. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aldeyra has no effect on the direction of NewAmsterdam Pharma i.e., NewAmsterdam Pharma and Aldeyra go up and down completely randomly.
Pair Corralation between NewAmsterdam Pharma and Aldeyra
Given the investment horizon of 90 days NewAmsterdam Pharma is expected to generate 0.67 times more return on investment than Aldeyra. However, NewAmsterdam Pharma is 1.49 times less risky than Aldeyra. It trades about 0.04 of its potential returns per unit of risk. Aldeyra is currently generating about 0.03 per unit of risk. If you would invest 1,253 in NewAmsterdam Pharma on September 1, 2024 and sell it today you would earn a total of 732.00 from holding NewAmsterdam Pharma or generate 58.42% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
NewAmsterdam Pharma vs. Aldeyra
Performance |
Timeline |
NewAmsterdam Pharma |
Aldeyra |
NewAmsterdam Pharma and Aldeyra Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with NewAmsterdam Pharma and Aldeyra
The main advantage of trading using opposite NewAmsterdam Pharma and Aldeyra positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NewAmsterdam Pharma position performs unexpectedly, Aldeyra can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aldeyra will offset losses from the drop in Aldeyra's long position.NewAmsterdam Pharma vs. Monte Rosa Therapeutics | NewAmsterdam Pharma vs. Inventiva Sa | NewAmsterdam Pharma vs. Cullinan Oncology LLC | NewAmsterdam Pharma vs. Compass Therapeutics |
Aldeyra vs. Tarsus Pharmaceuticals | Aldeyra vs. Travere Therapeutics | Aldeyra vs. Eton Pharmaceuticals | Aldeyra vs. Viridian Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |